CBF AML encompasses patients with t(8;21) or inv(16) cytogenetic rearrangements or their associated fusion genes, RUNX1-RUNX1T1 and CBFB-MYH11, respectively (57). Here, CEBPZ is linked to acute myeloid leukemia.